Villagonzalo, Janine T.
HRN: 25-81-03 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/02/2024
CEFUROXIME 750MG (VIAL)
09/02/2024
09/09/2024
IV
466 Mg
Q8hrs
UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes